Dental Practice EBITDA Multiples UK: 2026

The UK dental market is back. After a price correction in 2023 and a cautious 2024, Christie & Co's Business Outlook 2026 confirmed that confidence has returned, with average prices paid for dental businesses rising 2.9% across 2025. Corporate buyers are re-entering the market, lending conditions have improved, and 59% of dental professionals surveyed reported a positive outlook for 2026. If you own a dental practice and have been considering an exit, our dental M&A advisory service can help you understand what your practice is genuinely worth in this recovering market.

But valuation in dentistry is not straightforward. Your practice's EBITDA multiple depends on revenue mix, scale, location, team stability, and how reliant the business is on you as the principal. A two-surgery NHS practice in a secondary town and a six-surgery private group in central London sit at opposite ends of the spectrum - and their valuations reflect that.

This guide breaks down the EBITDA multiples dental practices are achieving in the UK right now, what drives those multiples higher or lower, and how to position your practice for a premium exit in 2026.

What EBITDA Means for Dental Practice Owners

EBITDA - Earnings Before Interest, Taxes, Depreciation, and Amortisation - has become the standard valuation metric for dental practice sales in the UK. Historically, practices were valued as a percentage of gross fees, typically 70% to 100% of turnover. That method still surfaces occasionally, but the rise of corporate dentistry and private equity investment has made EBITDA the dominant benchmark.

The key figure for dental valuations is "associate-led EBITDA" - the profit generated after replacing the principal's clinical production with an associate at market rate. This adjustment matters because buyers are purchasing the business, not hiring you. If you personally generate 40% of the practice revenue, a buyer needs to know what happens when you step back.

According to Oliver Snowden, an experienced dental M&A director featured on Dentists Who Invest, this principal-adjusted percentage typically ranges from 25% at the lower end to 40-42% at the absolute high, depending on how much clinical work the principal delivers. If you are running a larger practice and only delivering 20-25% of total revenue, the adjustment is closer to 30-32%.

Getting this number right is critical. Overstate your EBITDA and the deal collapses during due diligence. Understate it and you leave money on the table.

2026 EBITDA Multiples by Practice Type

The multiples your practice commands depend heavily on your revenue mix. The UK dental market has a clear hierarchy, and buyers price accordingly.

These figures draw from Christie & Co's market data, Move at Pace's 2026 UK benchmarks, and FOCUS Investment Banking's dental valuation analysis. They reflect completed transactions and active market conditions as of early 2026.

The standout data point from 2025 was Bridgepoint's acquisition of {my}dentist - the UK's largest dental provider - for approximately GBP 800 million. Samera's analysis of the deal calculated this at roughly 10x EBITDA on GBP 74 million of annual earnings across 600 practices. That transaction set a pricing benchmark for the sector and sent a clear signal about how institutional capital values dental assets.

EBITDA Multiples by Revenue Scale

Scale matters. Larger practices with mature infrastructure and multiple providers attract stronger multiples than single-surgery, owner-dependent operations.

This scaling effect is well documented. According to FOCUS Investment Banking, practices where the owner performs 90% or more of production may see valuation discounts of 10-20%, reinforcing why associate-driven models consistently achieve higher exit values.

What Drives Multiples Higher

Not every practice within a category achieves the top of its range. Several factors push your multiple upward - or drag it down.

Private Revenue Proportion

The single biggest multiplier enhancer. Practices with 60%+ private revenue consistently trade at the higher end. Private income is less regulated, offers higher margins, and gives the new owner pricing flexibility. The trend identified by Christie & Co's Dental Market Review shows a "progressive tilt toward private and mixed (private) acquisitions across all buyer types."

Team Stability and Associate Retention

A practice that retains its associates post-sale is worth significantly more than one where clinicians might leave when the principal exits. Long-term associate contracts, competitive compensation structures, and a strong practice culture all factor into the buyer's risk assessment.

Recurring Revenue and Recall Rates

Strong hygiene recall programmes translate directly into predictable future cash flow. Buyers want to see balanced hygiene-to-doctor production ratios, consistent scheduling, and data-backed patient retention metrics. Practices that can demonstrate 80%+ recall adherence command premium positioning in negotiations.

Clinical Infrastructure and Technology

Modern equipment reduces near-term capital expenditure requirements for the buyer. Digital workflows, CBCT scanning, intraoral scanners, and integrated practice management software all signal a well-invested business. As Christie & Co noted, "acceleration in the adoption of AI, CRM systems and fully integrated digital workflows is expected to be standard across well-run practices" by 2026.

Regulatory Standing

A clean record with the Care Quality Commission and the General Dental Council is non-negotiable. Any compliance issues, complaints history, or inspection failures will suppress your multiple or kill the deal entirely. The GDC register now stands at over 47,000 dentists as of January 2026, reflecting a 3%+ year-on-year increase, so buyer confidence in workforce availability is improving.

The Buyer Landscape in 2026

Understanding who is buying dental practices in the UK right now helps you position your exit correctly. Different buyer types pay different multiples and structure deals differently.

Corporate Groups

The top corporate players are {my}dentist with over 500 practices (now backed by Bridgepoint), BUPA Dental Care with approximately 389, PortmanDentex with around 380, and Rodericks Dental Partners with roughly 226, according to Business Sale Report's dental sector snapshot. Together, these groups account for a significant share of UK dental capacity.

Corporate purchasers represented just 7% of completed transactions through Christie & Co in 2025 - but that is changing. Their pipeline data shows approximately 20% of live transactions are now expected to complete into corporate ownership, suggesting renewed acquisitive appetite, particularly for private practices with strong EBITDA.

New Market Entrants

DeNovo Dental Partners launched into the UK market in 2025 with the acquisition of six practices across the South of England, introducing a shared ownership model. Upon selling, principals receive the full value of their practice, with the majority in cash and the remainder in parent company equity. This model, common internationally, is new to the UK and gives sellers an additional route to market.

First-Time Buyers

Perhaps the most significant trend of 2025 was the emergence of younger clinicians entering ownership. First-time buyers accounted for 33% of dental practices sold through Christie & Co. Improved lending conditions, with the Bank of England base rate reduced to 4%, and specialist lenders offering higher loan-to-value ratios made ownership more accessible.

Private Equity

PE interest in UK dental has never been stronger. The Bridgepoint/{my}dentist deal valued at approximately GBP 800 million, generating a reported 3.0x return for outgoing investor Palamon Capital Partners, demonstrates the scale of capital flowing into the sector. PE firms are particularly interested in multi-site groups that can serve as platforms for further bolt-on acquisitions.

For practice owners looking to understand who might be interested in acquiring their business, our buy-side advisory page outlines how we connect sellers with qualified, motivated buyers across all categories.

NHS Contract Reform: April 2026 Impact

A major development affecting NHS practice valuations is the contract reform package taking effect from 1 April 2026. The British Dental Association's detailed analysis outlines several changes that will influence how buyers assess NHS income streams.

Key changes include:

• Urgent care payments increasing by approximately 76% to GBP 75 per patient, up from roughly GBP 42.60 under the old 1.2 UDA model
• Three new complex care pathways for high-needs patients, paid at fixed national tariffs rather than variable local UDA rates
• Improved denture modification and repair reimbursement, with repairs moving from 1 UDA to 2 UDAs
• Funded peer review and clinical audit schemes reintroduced for an initial three-year period
• Fluoride varnish delivery by dental nurses at 0.5 UDAs as a standalone course of treatment

These reforms do not eliminate the UDA system - the BDA has been clear that this is "not the final destination" - but they do improve the economics of treating complex patients within NHS contracts. For sellers, this means NHS-heavy practices may see a modest uplift in buyer confidence, particularly where the practice's patient mix includes high-needs populations that will benefit from the new care pathways.

At a BDA webinar on the proposals, nearly 1,000 dentists attended, with 57% saying the changes would improve the NHS dental contract "somewhat or a lot." Cautious optimism, but movement in the right direction.

Preparing Your Practice for a Premium Exit

Preparation is where value is created - not at the point of sale. The most successful dental practice exits we advise on start 12-24 months before the owner goes to market. Here is what moves the needle.

Reduce Principal Dependence

This is the single most impactful preparation step. If your practice's EBITDA collapses when you stop treating patients, your multiple will reflect that risk. Begin transitioning your patients to associates, reduce your clinical days gradually, and demonstrate to buyers that the business operates profitably without your chairside production. Our guide to EBITDA optimisation covers specific strategies for maximising your adjusted earnings.

Clean and Document Your Financials

Monthly management accounts with clearly calculated adjusted EBITDA, revenue broken down by clinician and treatment type, and a three-year trend showing stability or growth. Buyers and their accountants will scrutinise every line. Personal expenses run through the business, inconsistent reporting periods, and missing data all erode trust and compress your multiple.

Strengthen Your Private Revenue

The market rewards private income growth. If you are running a mixed practice at 40% private, explore whether you can shift that to 50-60% over 12-18 months through cosmetic services, whitening, implant referrals, and plan-based preventive care. Every percentage point of private revenue lift makes your practice more attractive to the buyers paying the highest multiples.

Secure Your Team on Long-Term Contracts

Associate turnover is one of the biggest risks a buyer faces. Lock in your key clinicians with competitive remuneration, clear progression paths, and contracts that extend beyond the expected completion date. A stable team de-risks the acquisition and directly supports a higher multiple.

Address Any CQC or Compliance Issues

Resolve outstanding CQC actions, update your infection control protocols, ensure your radiography compliance is current, and verify that all team members have up-to-date GDC registrations and indemnity cover. Due diligence will surface every deficiency, and unresolved compliance matters can delay or derail a transaction.

Consider BADR Tax Planning

The Business Asset Disposal Relief (formerly Entrepreneurs' Relief) landscape changed in April 2026, with the CGT rate on qualifying disposals rising from 14% to 18%. If you have not already reviewed the tax implications of your planned exit, our detailed analysis of the BADR changes covers what dental practice owners need to know.

The Sale Process: What to Expect

A typical dental practice sale in the UK takes 6-12 months from initial engagement to completion, though complex multi-site transactions can take longer.

Months 1-2: Preparation and Valuation. Engage an M&A advisor, prepare your information memorandum, obtain a formal EBITDA-based valuation, and identify your target buyer profile.

Months 3-4: Marketing and Buyer Identification. Your advisor approaches qualified buyers confidentially, manages NDAs, and circulates the information memorandum to a curated shortlist.

Months 5-7: Offers and Negotiation. Review offers, negotiate heads of terms, and agree on deal structure including consideration split (cash vs. deferred), tie-in period, and any earn-out provisions.

Months 8-12: Due Diligence and Completion. Legal, financial, and operational due diligence by the buyer's team. CQC registration transfer (critical and often the longest element). Drafting and executing the sale and purchase agreement. Completion.

Most buyers will require the principal to remain for a tie-in period of 1-3 years to ensure smooth transition. The terms of this tie-in - your clinical commitment, remuneration during the period, and restrictive covenants - are among the most important points of negotiation.

Comparing Dental Valuations Across the Healthcare Sector

Dental sits at the premium end of UK healthcare M&A valuations. For context, here is how multiples compare across related sectors.

For a broader view of healthcare M&A activity, our analysis of healthcare business exits provides additional context on how the sector is performing.

Frequently Asked Questions

What is a good EBITDA multiple for a dental practice in the UK?

A "good" multiple depends on your practice type and scale. Single-surgery NHS practices typically achieve 5x-7x EBITDA, while well-run private or mixed practices with strong associate-led earnings can achieve 8x-10x+. Multi-site groups attracting PE interest regularly trade above 10x.

How do I calculate my dental practice EBITDA?

Start with your operating profit, then add back the principal's salary and benefits (replacing with a market-rate associate cost), one-off expenses, personal costs run through the business, and depreciation. The resulting figure is your adjusted or "normalised" EBITDA - the number buyers use to value your practice.

Are NHS dental practices still selling well in 2026?

Yes. After a period of correction from 2022-2024, NHS practice values strengthened in 2025 with goodwill rising and corporate buyers returning to the market. The April 2026 contract reforms, particularly improved urgent care payments, add modest support to NHS practice economics.

How long does it take to sell a dental practice?

Typically 6-12 months from engagement to completion. The CQC registration transfer process is often the longest component. Multi-site or complex transactions may take longer, particularly where multiple regulatory approvals are required.

What is associate-led EBITDA and why does it matter?

Associate-led EBITDA is the practice profit calculated after replacing the principal's clinical output with an associate at market rate. It shows buyers what the practice earns without the current owner's personal production. This is the figure that drives your valuation multiple.

Do I need to stay on after selling my dental practice?

In most cases, yes. Buyers typically require a tie-in period of 1-3 years to ensure continuity for patients and staff. The terms of this arrangement - clinical hours, compensation, and restrictive covenants - are negotiable and should be a key focus of your transaction planning.

What impact does CQC rating have on dental practice valuation?

A "Good" or "Outstanding" CQC rating supports buyer confidence and can be a prerequisite for certain corporate acquirers. Practices with "Requires Improvement" or "Inadequate" ratings will face significant valuation discounts or may struggle to attract offers at all.

How does the April 2026 NHS contract reform affect my practice value?

The reforms improve reimbursement for urgent care, complex treatments, and denture work, while maintaining the UDA-based framework. Practices that treat high-needs NHS patients may see improved economics, potentially supporting slightly stronger valuations for NHS-heavy practices.

What are corporate dental groups looking for in acquisitions?

Corporate buyers prioritise practices with strong EBITDA (ideally associate-led), stable teams, modern facilities, good CQC standing, and geographic fit with their existing network. Private or mixed practices with growth potential in cosmetic and specialist treatments are particularly sought after.

Should I sell to a corporate or an independent buyer?

Each route has trade-offs. Corporates typically offer faster completions, structured tie-in periods, and potentially higher headline prices for the right practices. Independent buyers may offer more flexibility on terms, shorter tie-ins, and a closer alignment with the way you have always run the practice. The right answer depends on your priorities, timeline, and what matters most beyond the price.

Take the Next Step

The UK dental M&A market in 2026 is active, competitive, and rewarding well-prepared sellers. Whether you are running a single-surgery mixed practice or a multi-site private group, understanding your EBITDA multiple - and what moves it - is the foundation of a successful exit.

If you are considering selling your dental practice, or simply want to understand what your business is worth in the current market, speak to our dental M&A advisory team. We provide confidential, evidence-based valuations that reflect genuine market conditions - not aspirational projections.

Your Advisory Team

Experienced Dealmakers Lead Your Exit

Every exit is led by a senior advisor who has been through it themselves. Meet the team who will guide you.

Joe Lewin

Founder & Lead Advisor

• •Built and sold first company after scaling to 80,000 users in 18 months
• •Raised £2m+ funding, built 12,000+ buyer network
• •Worked on 20+ transactions, spoken to hundreds of acquirers
• •Full-stack developer, building AI agents and SaaS platforms

Joe Thomason

Senior M&A Advisor

• •Previously Analyst at KBS Corporate
• •Analyst at Hampleton Partners, Associate at Tech Credit Partners
• •Worked on 25+ completed transactions (£300k to £120m)
• •Specialist in debt lending for business buyers

Emerson Patton

Sector Specialist: Building, Construction & Trade Services

• •20+ years advising owners in building services, fire safety, HVAC, plumbing, and construction
• •Guided 200+ companies through growth, profit improvement, and exit planning
• •Builds equity value and operational structure long before a sale
• •Partners with DFA to prepare owners for exit while the advisory team runs the sale

Sam Pouyan

Senior M&A Advisor

• •10 years across buy-side and sell-side M&A
• •Former investment banking analyst
• •Expert in financial modelling and deal structuring

Sage

AI Deal Concierge

• •Available 24/7. Monitors every signal in your deal
• •Keeps your advisory team one step ahead at all times
• •Trained on thousands of M&A transactions

Tim Armoo

Partner & Chief Marketing Officer

• •Founded Fanbytes, scaled revenues to £10m+, exited at multi-eight-figure valuation
• •Advises on multiple M&A deals, invests in early-stage ventures
• •Built 700,000+ follower community teaching founders to scale and sell
• •Partnered with DealFlowAgent to expand access for founders to buyers

Assigned Per Deal

Sector Expert

Industry-Specific M&A Advisor

For every deal, our advisory team includes a sector specialist from that client's specific industry and niche: bringing relationships, insider knowledge, and leverage to support your process and achieve the best acquisition outcome.

Dental Practices M&A Specialists

Thinking of selling your dental practices business?

DealFlowAgent is the UK and US's only M&A advisory firm specialising in dental practice businesses. Our trusted advisors leverage industry knowledge, buyer relationships and proprietary technology to help business owners secure multiple acquisition offers at higher valuations.

Talk to a Real Advisor - No Obligation

Speak with Joe or Sam about your situation. No hard sell, no commitment, just honest advice from advisors who've been through it.

What's Your Business Actually Worth?

Our valuation tool gives you a realistic range based on recent comparable transactions in your sector. Takes 3 minutes.

Related Articles